[HTML][HTML] Virus-like particle vaccinology, from bench to bedside

MO Mohsen, MF Bachmann - Cellular & molecular immunology, 2022 - nature.com
Virus-like particles (VLPs) have become key tools in biology, medicine and even
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …

[HTML][HTML] Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective

N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers

L Liu, Y Xie, H Yang, A Lin, M Dong, H Wang, C Zhang… - Imeta, 2023 - Wiley Online Library
The tumor immune microenvironment (TIME) is closely associated with tumor formation,
particularly linked to the human papillomavirus (HPV), and regulates tumor initiation …

[HTML][HTML] Human papillomavirus epidemiology and prevention: is there still a gender gap?

G Milano, G Guarducci, N Nante, E Montomoli, I Manini - Vaccines, 2023 - mdpi.com
Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

[HTML][HTML] Heparan sulfate and sialic acid in viral attachment: Two sides of the same coin?

IE Ramos-Martínez, E Ramos-Martínez… - International Journal of …, 2022 - mdpi.com
Sialic acids and heparan sulfates make up the outermost part of the cell membrane and the
extracellular matrix. Both structures are characterized by being negatively charged, serving …

[HTML][HTML] Human papilloma virus: an unraveled enigma of universal burden of malignancies

I Khan, R Harshithkumar, A More, A Mukherjee - Pathogens, 2023 - mdpi.com
HPV, or Human Papilloma Virus, has been the primary causative agent of genital warts and
cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of …

[HTML][HTML] Navigating therapeutic strategies: HPV classification in head and neck cancer

H Tabatabaeian, Y Bai, R Huang, A Chaurasia… - British Journal of …, 2024 - nature.com
Abstract The World Health Organisation recognised human papillomavirus (HPV) as the
cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA …

[HTML][HTML] Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review

K Devaraja, S Aggarwal, M Singh - Vaccines, 2023 - mdpi.com
Therapeutic vaccination is one of the most effective immunotherapeutic approaches, second
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …

Current status and future directions for the development of human papillomavirus vaccines

R Wang, H Huang, C Yu, X Li, Y Wang… - Frontiers in …, 2024 - frontiersin.org
The development of human papillomavirus (HPV) vaccines has made substantive progress,
as represented by the approval of five prophylactic vaccines since 2006. Generally, the …

[HTML][HTML] Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors

C Ma, M Zou, N Xu, Y Liu, Y Wang - Frontiers in Cellular and Infection …, 2024 - frontiersin.org
Cervical cancer is the third most common cancer threatening women's health globally, and
high-risk human papillomavirus (HR-HPV) infection is the main cause of cervical cancer …